annual net income:
$858.98M-$275.85M(-24.31%)Summary
- As of today (April 26, 2025), RPRX annual net profit is $858.98 million, with the most recent change of -$275.85 million (-24.31%) on December 31, 2024.
- During the last 3 years, RPRX annual net income has risen by +$239.25 million (+38.61%).
- RPRX annual net income is now -63.42% below its all-time high of $2.35 billion, reached on December 31, 2019.
Performance
RPRX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$208.21M-$335.77M(-61.72%)Summary
- As of today (April 26, 2025), RPRX quarterly net profit is $208.21 million, with the most recent change of -$335.77 million (-61.72%) on December 31, 2024.
- Over the past year, RPRX quarterly net income has dropped by -$286.13 million (-57.88%).
- RPRX quarterly net income is now -85.34% below its all-time high of $1.42 billion, reached on December 31, 2019.
Performance
RPRX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$858.98M-$286.13M(-24.99%)Summary
- As of today (April 26, 2025), RPRX TTM net profit is $858.98 million, with the most recent change of -$286.13 million (-24.99%) on December 31, 2024.
- Over the past year, RPRX TTM net income has dropped by -$275.85 million (-24.31%).
- RPRX TTM net income is now -63.42% below its all-time high of $2.35 billion, reached on December 31, 2019.
Performance
RPRX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RPRX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.3% | -57.9% | -24.3% |
| 3 y3 years | +38.6% | -57.9% | -24.3% |
| 5 y5 years | -63.4% | -57.9% | -24.3% |
RPRX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.3% | +1905.5% | -61.7% | +145.7% | -25.0% | +1905.5% |
| 5 y | 5-year | -63.4% | +1905.5% | -61.7% | +145.7% | -63.3% | +1905.5% |
| alltime | all time | -63.4% | +1905.5% | -85.3% | +145.7% | -63.4% | +1905.5% |
Royalty Pharma Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $858.98M(-24.3%) | $208.21M(-61.7%) | $858.98M(-25.0%) |
| Sep 2024 | - | $543.99M(+433.3%) | $1.15B(+70.1%) |
| Jun 2024 | - | $102.00M(+2034.9%) | $673.24M(-15.7%) |
| Mar 2024 | - | $4.78M(-99.0%) | $798.86M(-29.6%) |
| Dec 2023 | $1.13B(+2549.5%) | $494.34M(+585.5%) | $1.13B(+515.4%) |
| Sep 2023 | - | $72.11M(-68.3%) | $184.41M(-27.7%) |
| Jun 2023 | - | $227.63M(-33.2%) | $254.95M(-23.2%) |
| Mar 2023 | - | $340.75M(-174.7%) | $331.83M(+674.7%) |
| Dec 2022 | $42.83M(-93.1%) | -$456.08M(-419.7%) | $42.83M(-91.5%) |
| Sep 2022 | - | $142.65M(-53.2%) | $506.82M(+8.7%) |
| Jun 2022 | - | $304.50M(+488.3%) | $466.10M(-22.6%) |
| Mar 2022 | - | $51.76M(+554.9%) | $602.37M(-2.8%) |
| Dec 2021 | $619.73M | $7.90M(-92.2%) | $619.73M(-20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $101.93M(-76.9%) | $782.92M(-19.4%) |
| Jun 2021 | - | $440.78M(+537.7%) | $971.62M(-0.1%) |
| Mar 2021 | - | $69.12M(-59.6%) | $972.92M(-0.2%) |
| Dec 2020 | $975.04M(-58.5%) | $171.09M(-41.1%) | $975.04M(-56.2%) |
| Sep 2020 | - | $290.63M(-34.3%) | $2.22B(-5.1%) |
| Jun 2020 | - | $442.07M(+520.5%) | $2.34B(+14.1%) |
| Mar 2020 | - | $71.24M(-95.0%) | $2.05B(-12.6%) |
| Dec 2019 | $2.35B(+70.5%) | $1.42B(+247.3%) | $2.35B(+153.0%) |
| Sep 2019 | - | $408.98M(+169.6%) | $928.14M(+78.8%) |
| Jun 2019 | - | $151.71M(-58.7%) | $519.16M(+41.3%) |
| Mar 2019 | - | $367.44M | $367.44M |
| Dec 2018 | $1.38B(+13.9%) | - | - |
| Dec 2017 | $1.21B | - | - |
FAQ
- What is Royalty Pharma annual net profit?
- What is the all time high annual net income for Royalty Pharma?
- What is Royalty Pharma annual net income year-on-year change?
- What is Royalty Pharma quarterly net profit?
- What is the all time high quarterly net income for Royalty Pharma?
- What is Royalty Pharma quarterly net income year-on-year change?
- What is Royalty Pharma TTM net profit?
- What is the all time high TTM net income for Royalty Pharma?
- What is Royalty Pharma TTM net income year-on-year change?
What is Royalty Pharma annual net profit?
The current annual net income of RPRX is $858.98M
What is the all time high annual net income for Royalty Pharma?
Royalty Pharma all-time high annual net profit is $2.35B
What is Royalty Pharma annual net income year-on-year change?
Over the past year, RPRX annual net profit has changed by -$275.85M (-24.31%)
What is Royalty Pharma quarterly net profit?
The current quarterly net income of RPRX is $208.21M
What is the all time high quarterly net income for Royalty Pharma?
Royalty Pharma all-time high quarterly net profit is $1.42B
What is Royalty Pharma quarterly net income year-on-year change?
Over the past year, RPRX quarterly net profit has changed by -$286.13M (-57.88%)
What is Royalty Pharma TTM net profit?
The current TTM net income of RPRX is $858.98M
What is the all time high TTM net income for Royalty Pharma?
Royalty Pharma all-time high TTM net profit is $2.35B
What is Royalty Pharma TTM net income year-on-year change?
Over the past year, RPRX TTM net profit has changed by -$275.85M (-24.31%)